X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Fact Sheet, Lupin Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Fact Sheet   (LUPL)

Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN LTD Price History

Price Rs 799.8
Mkt Cap Rs m 360,821
Vol '000 166.4
P/E X 143.7
P/CF X 10.4
EPS (TTM) Rs 5.6
% ch % -0.1
No. of shares m 451.14
% ch week % -2.3
% ch 1-mth % -12.5
% ch 12-mth % -30.0
52 week H/L Rs 1,174.9/723.6
(As on Jul 23, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN LTD Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
LUPIN LTD EQUITY SHARE DATA
High Rs6391,0032,0372,1271,750 
Low Rs5076069041,2941,384 
Sales per share (Unadj.) Rs215.4251.7280.3316.4387.4 
Earnings per share (Unadj.) Rs29.441.053.550.256.6 
Diluted earnings per shareRs29.140.753.350.156.7 
Cash flow per share (Unadj.) Rs36.846.863.161.076.8 
Dividends per share (Unadj.) Rs4.006.007.507.507.50 
Adj. dividends per shareRs3.975.967.477.497.51 
Dividend yield (eoy) %0.70.70.50.40.5 
Book value per share (Unadj.) Rs116.3154.6204.1247.8298.9 
Adj. book value per shareRs115.4153.6203.3247.4299.2 
Shares outstanding (eoy) m447.53448.38449.49450.58451.58 
Bonus/Rights/Conversions  -ESOPESOP-ESOPS 
Price / Sales ratio x2.73.25.25.44.0 
Avg P/E ratio x19.519.627.534.127.7 
P/CF ratio (eoy) x15.617.223.328.020.4 
Price / Book Value ratio x4.95.27.26.95.2 
Dividend payout %13.614.614.014.913.2 
Avg Mkt Cap Rs m256,435360,767660,975770,740707,513 
No. of employees `000NANA14.216.416.8 
Total wages/salary Rs m12,66614,64717,47321,41628,495 
Avg. sales/employee Rs ThNMNM8,874.38,718.510,418.3 
Avg. wages/employee Rs ThNMNM1,230.71,309.81,697.0 
Avg. net profit/employee Rs ThNMNM1,692.71,382.61,523.0 
LUPIN LTD INCOME DATA
Net Sales Rs m96,413112,866125,997142,555174,943 
Other income Rs m2791,1652,3981,8521,065 
Total revenues Rs m96,692114,031128,395144,407176,008 
Gross profit Rs m22,70030,02836,19636,85444,931 
Depreciation Rs m3,3222,6104,3474,8719,122 
Interest Rs m410267985951,525 
Profit before tax Rs m19,24628,31734,14833,23935,349 
Minority Interest Rs m-263-331-412-88-72 
Prior Period Items Rs m0004983 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m5,8429,6229,70410,5939,785 
Profit after tax Rs m13,14218,36424,03222,60725,575 
Gross profit margin %23.526.628.725.925.7 
Effective tax rate %30.434.028.431.927.7 
Net profit margin %13.616.319.115.914.6 
LUPIN LTD BALANCE SHEET DATA
Current assets Rs m51,43161,00578,04098,874119,542 
Current liabilities Rs m30,06926,29634,63350,61261,206 
Net working cap to sales %22.230.834.533.933.3 
Current ratio x1.72.32.32.02.0 
Inventory Days Days7469738476 
Debtors Days Days83807711690 
Net fixed assets Rs m28,03630,01949,213114,194131,660 
Share capital Rs m895897899901903 
"Free" reserves Rs m49,55467,92290,833110,733134,073 
Net worth Rs m52,04269,31691,732111,634134,976 
Long term debt Rs m2,4711,5101,01853,73956,478 
Total assets Rs m89,139102,060132,610226,249266,073 
Interest coverage x47.9107.3349.156.924.2 
Debt to equity ratio x0000.50.4 
Sales to assets ratio x1.11.11.00.60.7 
Return on assets %15.218.318.210.310.2 
Return on equity %25.326.526.220.318.9 
Return on capital %35.639.936.520.419.3 
Exports to sales %44.850.746.447.20 
Imports to sales %8.78.68.87.20 
Exports (fob) Rs m43,15757,17758,48267,2440 
Imports (cif) Rs m8,3919,65411,05710,1990 
Fx inflow Rs m44,74963,07662,59371,40581,885 
Fx outflow Rs m13,82016,48016,59217,80721,506 
Net fx Rs m30,92946,59646,00153,59860,378 
LUPIN LTD CASH FLOW
From Operations Rs m 12,510 20,039 27,331 -3,824 41,148 
From Investments Rs m -5,219 -8,585 -10,545 -69,617 -25,287 
From Financial Activity Rs m -6,628 -8,571 -1,969 58,364 4,332 
Net Cashflow Rs m 663 2,883 14,817 -15,077 20,193 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.9

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare LUPIN LTD With:   GSK PHARMA  FDC LTD.  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 222 Points Higher; Telecom and FMCG Stocks Witness Buying(Closing)

Indian share markets continued their momentum and ended the day on a positive note today. Gains were largely seen in the telecom sector and FMCG sector.

Views on news

LUPIN LTD Announces Quarterly Results (4QFY18); Net Profit Down 305.5% (Quarterly Result Update)

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, LUPIN LTD has posted a net profit of Rs 8 bn (down 305.5% YoY). Sales on the other hand came in at Rs 40 bn (down 5.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - MYLAN COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS